Skip to content

Zituvio

Published: July 26, 2026Updated: August 27, 2026

Zituvio is a brand-name medication containing sitagliptin, a DPP-4 inhibitor used to manage blood sugar levels in adults with type 2 diabetes. It is typically prescribed alongside diet and exercise to improve glycemic control. This medication may be used alone or in combination with other diabetes medications, depending on individual patient needs.

Quick summary

Zituvio is a DPP-4 inhibitor used to help control blood sugar in adults with type 2 diabetes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

RxNorm
2670442
Generic
Zituvio
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Zituvio is indicated for improving glycemic control in adults with type 2 diabetes mellitus. It is used as an adjunct to diet and exercise and may be prescribed as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin.

Zituvio contains sitagliptin, which works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4). This enzyme breaks down incretin hormones. By inhibiting DPP-4, the medication increases insulin secretion and decreases glucagon release in a glucose-dependent manner, helping to lower blood sugar levels after meals and fasting.

Zituvio is not indicated for use in patients with type 1 diabetes or diabetic ketoacidosis. Common side effects may include upper respiratory infections, headache, and nasopharyngitis. Patients should report symptoms of pancreatitis, severe joint pain, or heart failure symptoms while taking this medication. Regular monitoring of blood glucose and renal function may be recommended.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy